Taro Pharmaceutical Industries Ltd

GOLDMAN SACHS GROUP INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

5/14/2024

Shares

5,642

Value ($000)

236

Weight

0.0%

2013 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	5/14/2024	236	0.0%	5,642	12/31/2023
2023 Q3	5/15/2024	668	0.0%	17,714	9/30/2023
2023 Q2	5/14/2024	367	0.0%	9,670	6/30/2023
2022 Q3	5/14/2024	235	0.0%	7,854	9/30/2022
2022 Q2	5/14/2024	636	0.0%	17,597	6/30/2022
2022 Q1	5/16/2022	388	0.0%	8,962	3/31/2022
2021 Q4	2/17/2022	410	0.0%	8,174	12/31/2021
2021 Q3	1/20/2022	565	0.0%	8,876	9/30/2021
2021 Q2	8/13/2021	1,101	0.0%	15,287	6/30/2021
2021 Q1	5/17/2021	1,297	0.0%	17,581	3/31/2021
2020 Q4	2/12/2021	1,040	0.0%	14,164	12/31/2020
2020 Q3	11/13/2020	1,065	0.0%	19,415	9/30/2020
2020 Q2	8/12/2020	1,047	0.0%	15,747	6/30/2020
2020 Q1	5/15/2020	1,649	0.0%	26,946	3/31/2020
2019 Q4	2/14/2020	1,111	0.0%	12,633	12/31/2019
2014 Q1	5/15/2014	219	0.0%	1,969	3/31/2014
2013 Q4	2/14/2014	289	0.0%	2,918	12/31/2013